Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
OtherEvidence-Based Clinical Medicine

Transcranial Doppler: An Introduction for Primary Care Physicians

Mounzer Y. Kassab, Arshad Majid, Muhammad U. Farooq, Hend Azhary, Linda A. Hershey, Edward M. Bednarczyk, Dion F. Graybeal and Mark D. Johnson
The Journal of the American Board of Family Medicine January 2007, 20 (1) 65-71; DOI: https://doi.org/10.3122/jabfm.2007.01.060128
Mounzer Y. Kassab
MD, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arshad Majid
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad U. Farooq
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hend Azhary
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda A. Hershey
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward M. Bednarczyk
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dion F. Graybeal
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark D. Johnson
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Transcranial Doppler (TCD) is a diagnostic tool that can be used at bedside to assess the cerebral vasculature noninvasively. It is inexpensive, safe, and reliable when compared with other techniques. It can be repeated multiple times and can be used for continuous monitoring if needed. Screening of children with sickle cell disease to assess and prevent ischemic strokes and monitoring for vasospasm after subarachnoid hemorrhage are well established, evidenced based utilizations of TCD. It is useful for the evaluation of occlusive intracranial vascular lesions with many emerging indications in the management of ischemic stroke. TCD with micro-bubble enhancement has comparable sensitivity to transesophageal echocardiogram in detecting right-to-left atrial cardiac shunts. TCD is underused as a clinical tool despite well established indications. The pressure to contain increasing medical cost will likely result in increased utilization of this test in future.

Christian Johann Doppler, a mathematician, physician, and astronomer, first described the Doppler principle in 1843. Its use in neurology was first reported in 1982,1 and since then, its convenience and growing range of uses have made it an attractive tool to evaluate the cerebrovascular tree in patients with neurovascular disorders. Transcranial Doppler (TCD) is a noninvasive ultrasound device that allows real-time evaluation of the intracranial cerebral circulation. It is currently under-utilized in part due to the lack of awareness about the diagnostic usefulness of this test. In this article, we will review TCD testing as a procedure and discuss its clinical applications of special interest to the primary care physician.

Examination and Doppler Instrument

Ultrasound examination of a vessel by means of TCD is referred to as insonation. The TCD probe is placed over different “acoustic windows” that are specific areas of skull where there is a lack of boney covering or the cranial bone is thin (Figure 1). The transtemporal (temporal) window is used to insonate the middle cerebral artery (MCA), the anterior cerebral artery (ACA), the posterior cerebral artery (PCA), and the terminal portion of the internal carotid artery (TICA), before its bifurcation. The transorbital (orbital) window gives access to insonate the ophthalmic artery (OA) as well as the internal carotid artery at the siphon level. The transforaminal (occipital) window allows insonation of the distal vertebral arteries (VA) and the basilar artery (BA). Finally, the submandibular window allows insonation of the more distal portions of the extracranial internal carotid artery.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

TCD probe positions over different acoustic windows of the skull.

TCD does not allow direct visualization of insonated vessels like carotid Doplex, rather it is an indirect evaluation by means of an ultrasonic beam of 2 MHz frequency that is produced from piezoelectric crystals that have been stimulated electrically. This beam bounces off the erythrocytes within the insonated artery. The reflected signal is received by the transducer and converted to an electric signal (Figure 2). This information is subtracted from the transmitted signal and then processed to obtain a waveform that allows accurate determination of blood flow velocities, direction of flow, and also allows for certain calculated parameters to be added to the evaluation. The pulsatility index (PI) is one of the useful calculated parameters, and it is considered a reliable marker of resistance distal to the insonated site. It is usually calculated by the Gosling equation.2 PI = (Peak systolic velocity − end diastolic velocity)/mean velocity.

Figure 2.
  • Download figure
  • Open in new tab
Figure 2.

TCD screen waveform with velocity scale on the left.

Introduction to Basic Cerebrovascular Hemodynamics

The relationship between resistance, pressure, and flow can be expressed by Ohm’s law: flow = pressure/resistance. If we want to apply this relationship to cerebrovascular hemodynamics it translates to cerebral blood flow = cerebral perfusion pressure/cerebrovascular resistance (CBF = CPP/CVR).

CPP can be calculated from the mean arterial blood pressure and the intracranial pressure (CPP = MAPB-ICP). CVR is influenced in physiologic states by constriction and dilatation of the small size vessels (arterioles) in the brain. In pathologic states, focal changes in resistance can be seen immediately behind an area of significant stenosis.

The main goal of brain cerebrovascular hemodynamics is to keep CBF stable despite alterations in CPP and CVR. This is usually achieved by vascular autoregulation, a process that lowers resistance by inducing vasodilatation to maintain CBF when CPP is decreased. In cases of increased CPP (like increased BP), increasing resistance by vasoconstriction occurs, and thus CBF is maintained.

TCD Examination and Interpretation of Findings

Different depth range, flow direction, and normal age-related flow velocity (FV) ranges have been established for each vessel. The vessels are identified using these parameters for each of the windows already discussed. Table 1 is a simplified illustration of these values.3 TCD measurements are influenced by different physiologic and pathologic factors and by vasoactive medications (Table 2).

View this table:
  • View inline
  • View popup
Table 1.

Accepted Guidelines for a Normal TCD Study

View this table:
  • View inline
  • View popup
Table 2.

Effects of Different Physiological States on TCD Flow Velocity

Basic Observations Regarding Blood FVs and PI in Different Vascular Scenarios

  1. Pure focal narrowing at the site of insonation will cause an increase in FV.

  2. Narrowing or obstructing lesions proximal to the insonation site will cause a decrease in FV observed at the insonation site.

  3. Downstream (distal) decrease in vascular resistance (as in the presence of arteriovenous malformation will increase FV and decrease PI at the site of insonation.

  4. Downstream increased vascular resistance (as in stenosis or obstruction) will decrease FV and increase PI proximal to lesion.

Clinical Applications

The clinical applications of TCD are growing. The American Academy of Neurology published TCD guidelines for clinicians.4 Although directed to neurologists, these guidelines may be useful for the primary care physician.

Sickle Cell Disease

This may be one of the most important TCD applications, and it is of very special interest for the primary care physician. Recent guidelines regard the use of TCD4 as a type A level of evidence (established as useful predictive for suspected condition), and class I (evidence provided by prospective studies in broad spectrum of persons with suspected condition) screening tool to assess stroke risk in children aged 2 to 16 years with sickle cell disease.

Sickle cell disease is associated with progressive occlusion of large intracranial arteries (most frequently the intracranial ICA and MCA). Total occlusion of any one of these arteries will lead to a massive stroke. These arteries are very accessible to TCD insonation and TCD can monitor FVs over time.

According to the TCD criteria for sickle cell disease, a MFV of up to 170 cm/s is considered normal and a MFV of 171 to 199 cm/s is called “conditional.” MFV of equal or greater than 200 cm/s is considered abnormal and require transfusion.5

A mean FV (MFV) of 200 cm/s or greater is accompanied by a stroke risk of 40% within the next 3 years. Transfusion, with reduction of hemoglobin S to less than 30% of total hemoglobin, will lower this risk by 70% compared with standard care alone.5–8 An optimal timing to re-screen children with sickle cell disease and normal TCD is not set, but a repeat TCD examination every 6 months seems to be a reasonable objective.

Intracranial Vasospasm

Intracranial vasospasm is the constriction of cerebral blood vessels due to the presence of blood in the subarachnoid space after a trauma or rupture of cerebral aneurysm. The vasospasm—if severe—may result in ischemia to the brain and is associated with an increase in mortality of 1.5- to 3-fold during the first 2 weeks after subarachnoid hemorrhage (SAH).9 Vasospasm typically occurs within 3 to 21 days after SAH and may last for 12 to 16 days.10 Clinically this manifests a deterioration of the patient’s level of consciousness, new focal neurological signs, and headaches.

The pathophysiological changes that underlie vascular constriction after SAH is not completely known but may include changes within the vessel walls themselves, alteration of levels of vasoactive substances, and broader pathologic conditions such as immune responses, inflammation, and oxidative damage.

Subarachnoid hemorrhage occurs in an estimated 25,000 to 30,000 people in the United States each year.10 It could be identified by TCD up to 1 to 2 days before it becomes clinically symptomatic allowing for immediate initiation of triple H therapy.

Vasospasm that follows SAH causes increased FV inside intracranial vessels. This can be detected by TCD indicating the need for treatments before the onset of ischemia. TCD is already in use to diagnose and monitor management of vasospasm in emergency and critical settings according to established guidelines.11–16 Usually a baseline TCD is performed at the earliest possible time (day 0); a daily TCD is then performed during days 3 to 10. A mean FV of 120 cm/s is considered a sign of mild spasm and a value above 180 cm/s is considered a sign of severe spasm. Mean FV obtained by TCD was found to correlate well with the angiographic residual lumen diameter of the MCA, and it was found to have excellent specificity (100%) but only good sensitivity (58.6%) in diagnosing vasospasm only due to the involvement of vessels that are not evaluated by TCD at times.13 The accuracy of TCD in the diagnosis of cerebral vasospasm can be increased by using the Lindegaard ratio (see Table 3). By calculating the MFV ratio between MCA, ACA, and the ipsilateral ICA (VMCA/VICA or VACA/VICA), changes due to generalized hyperemia can be distinguished from vasospasm.17

View this table:
  • View inline
  • View popup
Table 3.

TCD’s Mean Flow Velocity Criteria for Cerebral Vasospasm

Arterial Stenosis and Occlusion

TCD measurements that correlate with stenosis would be increase FV at the stenotic site.

  1. Decrease FV downstream from a stenotic site.

  2. Decrease FV proximal and increase PI proximal to the stenotic site.

  3. Increase FV and/or reverse flow in collateral vessels (like the finding of reverse blood flow in the OA in case of ipsilateral carotid artery occlusion and the finding of increased FV of the first segment of contralateral ACA shunting blood through the anterior communicating artery to the contralateral hemisphere in the same scenario).

In a case of total occlusion, there should be no flow signal from the occluded site. Increased velocity and/or reversed flow in the collateral vessels may also be seen. Other vessels in the same window should be accessible for insonation. A decrease in blood FV proximal to the site of the occlusion may also be seen. The presence of multiple findings described above increase the likelihood of the presence of stenosis or occlusion in a given vessel.18

Similar TCD approaches are already utilized in some centers for the detection of occluded vessels in acute and subacute stroke. It is the noninvasive test of choice to evaluate the cerebrovascular tree when a contraindication exists to the use of MRI and CT and cerebral angiography. TCD testing has a high positive predictive value of >80%19 making TCD an attractive tool for assessing the cerebrovascular tree in low risk patients.

In the Midwestern region of the United States, Medicare pays $62.31 for the professional component and $465.30 for the technical component of MRA of the intracranial vessels and pays additional and a similar amount for MRA of the cervical vessels. It only pays $51.99 for the professional component and $245.47 for a complete TCD study (for both intracranial and extracranial vessels). Since TCD is a noninvasive20,21 and inexpensive technique with no known risks or side effects, it can be an excellent tool for frequent follow-up of vascular lesions to assess effectiveness of a therapy without the concern of subjecting the patient to frequent radiation and the increasing costs of diagnostic testing like MRI.

TCD can also be used to observe the effectiveness of thrombolytic treatment in stroke patients. If the vessel is not recannulized, other treatments can be considered.21

Monitoring for Sources of Emboli and Heart Shunts during Procedures

Microemboli traveling along an insonated vessel will appear as high intensity transient signals (HITS) on the TCD spectrum. Although the exact clinical relevance of these findings remains uncertain, it may identify high-risk status for clinical stroke offering an opportunity to localize the source in patients with multiple potential sources and providing a possible monitoring tool for the efficacy of a chosen treatment.

TCD can also be used as a quality control, training, and monitoring tool inside operation rooms for surgeries with risk of embolization22–24 their contribution to the postoperative neurobehavioral changes.

TCD can detect the presence of right-to-left shunts such as patent foramen ovale (PFO) in patients with contraindications to transesophageal echo (TEE) with similar sensitivity and specificity25–28. This clinic use requires the administration of agitated saline after which the patient performs a valsalva maneuver28. The test is positive for right-to-left shunt if a shower of high signal material (air) is detected in the MCA by TCD 5 to 10 seconds after the intravenous injection of 10 mL of agitated saline26. If this shower of air emboli is detected after a minute of injection, it might indicate the presence of a pulmonary shunt; a diagnosis that cannot be obtained by TEE.

Brain Death (cerebral circulatory arrest)

TCD evaluation of a brain death patient yields a “reverberating or oscillating” pattern of flow (normal arterial blood flow in systole and reversed flow in diastole secondary to the very high distal brain resistant in the brain dead patients) leading to absence of net flow per unit of time.29–32 The reverberating pattern may progress to “no flow” in the advanced stages of brain death. Although it is not a common practice to get a TCD as part of a brain death examination, it can, however, be used as a useful adjunct test.33

Testing for Cerebrovascular Autoregulation

Cerebral autoregulation is the ability to maintain the cerebral blood flow despite minute-to-minute variation in cerebral perfusion rate. In a normal physiologic state, this can be achieved by the arteriolar control over the cerebral peripheral vascular resistance. People with impaired cerebral autoregulation might have a variety of presentations such as headache, dizziness, and syncope.

TCD measurements of FV and PI before and during pharmacological or mechanical manipulation of autoregulation and systemic blood pressure can be used to monitor the reactivity of the intracranial vasculature tree. Breath-holding and acetazolamide administration are two of the most used maneuvers to manipulate cerebral autoregulation.34–36

The breath-holding test is used to assess cerebrovascular reactivity to hypercapnia as calculated by means of the breath-holding index (BHI). The index is calculated by dividing the percent increase in mean FV (MFV) during breath-holding by the breath-holding time (in seconds) that subjects held their breath after a normal inspiration: BHI = {[MFV at the end of breath-holding − resting MFV]/resting MFV} × (100/seconds of breath-holding).

This technique can be useful in testing the candidacy of asymptomatic patients with internal carotid artery stenosis for endarterectomy surgery. Recent data37 showed increased risk of ischemic strokes in patients with severe (>70%) carotid stenosis and impaired autoregulation as tested by TCD. TCD can also assess the potential risk of cerebral ischemia in patients with carotid stenosis going for major anesthesia and surgery. TCD might also be a useful investigation in work up of a patient with vasovagal syncope38–41.

Conclusion: Advantages and Limitations of TCD

TCD is relatively inexpensive, noninvasive, portable and fairly easy to use. It allows frequent repeated measurements and continuous monitoring. Immediate, real time detection of changes in cerebrovascular hemodynamics is possible. It can be utilized by any medical specialty to evaluate several neurovascular disorders.

In many communities (especially rural ones), there is no neurologist and/or MRI machine available for appropriate stroke workup. In those settings and in many other places a “complete” stroke workup consists of carotid Doppler and two-dimensional echocardiogram. This misses the important evaluation of intracranial vasculature. A TCD may be the inexpensive, simple mean to determine which patients must be referred to a specialized center for further evaluation. In addition, and in patients who decline intervention initially, TCD gives a tool for monitoring the identified lesions through the years and evaluate the effectiveness of medical treatment.

Finally, TCD may be the only mean possible to evaluate intracranial vessels in cases when other radiographic means are contraindicated. TCD is a “blind procedure”; its accuracy relies on the knowledge and experience of a trained technician and interpreter. It has limited ability to detect distal branches of intracranial vessels. In 5% to 10% of cases, sufficient penetration of the bone window can not be achieved for ample insonation.

A certificate in neurosonology (TCD and carotid Doppler) is granted by the American neuroimaging society after specific training requirements are met and an examination is passed.

Notes

  • This article was externally peer reviewed.

    Conflict of interest: none declared.

  • Received for publication August 4, 2006.
  • Revision received October 17, 2006.
  • Accepted for publication October 21, 2006.

References

  1. ↵
    Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57: 769–74.
    OpenUrlCrossRefPubMed
  2. ↵
    Padayachee TS, Kirkham FJ, Lewis RR, Gillard J, Hutchinson MC, Gosling RG. Transcranial measurement of blood velocities in the basal cerebral arteries using pulsed Doppler ultrasound: a method of assessing the Circle of Willis. Ultrasound Med Biol 1986; 12: 5–14.
    OpenUrlCrossRefPubMed
  3. ↵
    Ringelstein EB, Kahlscheuer B, Niggemeyer E, Otis SM. Transcranial Doppler sonography: anatomical landmarks and normal velocity values. Ultrasound Med Biol 1990; 16: 745–61.
    OpenUrlCrossRefPubMed
  4. ↵
    Sloan MA, Alexandrov AV, Tegeler CH, et al. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004; 62: 1468–81.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5–11.
    OpenUrlCrossRefPubMed
  6. Adams RJ, McKie VC, Carl EM, et al. Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997; 42: 699–704.
    OpenUrlCrossRefPubMed
  7. Adams RJ, McKie VC, Brambilla D, et al. Stroke prevention trial in sickle cell anemia. Control Clin Trials 1998; 19: 110–29.
    OpenUrlCrossRefPubMed
  8. ↵
    Adams R, McKie V, Nichols F, et al. The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med 1992; 326: 605–10.
    OpenUrlCrossRefPubMed
  9. ↵
    Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurgery 2001; 48: 249–61; Discussion 261–2.
    OpenUrlCrossRefPubMed
  10. ↵
    Oyama K, Criddle L. Vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Nurse 2004; 24: 58–60, 62, 64–7.
    OpenUrlFREE Full Text
  11. ↵
    Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg 1984; 60: 37–41.
    OpenUrlCrossRefPubMed
  12. Grosset DG, Straiton J, du Trevou M, Bullock R. Prediction of symptomatic vasospasm after subarachnoid hemorrhage by rapidly increasing transcranial Doppler velocity and cerebral blood flow changes. Stroke 1992; 23: 674–9.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Sloan MA, Haley EC, Jr., Kassell NF, et al. Sensitivity and specificity of transcranial Doppler ultrasonography in the diagnosis of vasospasm following subarachnoid hemorrhage. Neurology 1989; 39: 1514–8.
    OpenUrlAbstract/FREE Full Text
  14. Harders AG, Gilsbach JM. Time course of blood velocity changes related to vasospasm in the circle of Willis measured by transcranial Doppler ultrasound. J Neurosurg 1987; 66: 718–28.
    OpenUrlCrossRefPubMed
  15. Aaslid R, Huber P, Nornes H. A transcranial Doppler method in the evaluation of cerebrovascular spasm. Neuroradiology 1986; 28: 11–6.
    OpenUrlCrossRefPubMed
  16. ↵
    Grosset DG, Straiton J, McDonald I, Cockburn M, Bullock R. Use of transcranial Doppler sonography to predict development of a delayed ischemic deficit after subarachnoid hemorrhage. J Neurosurg 1993; 78: 183–7.
    OpenUrlPubMed
  17. ↵
    Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. Acta Neurochir Suppl (Wien) 1988; 42: 81–4.
    OpenUrlCrossRefPubMed
  18. ↵
    Demchuk AM, Christou I, Wein TH, et al. Accuracy and criteria for localizing arterial occlusion with transcranial Doppler. J Neuroimaging 2000; 10: 1–12.
    OpenUrlPubMed
  19. ↵
    Alexandrov AV, Demchuk AM, Wein TH, Grotta JC. Yield of transcranial Doppler in acute cerebral ischemia. Stroke 1999; 30: 1604–9.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Constantoyannis C, Kourtopoulos H. [Transcranial Doppler in neurosurgery. A non-invasive method in the diagnosis of vasospasm and subarachnoid hemorrhage]. Lakartidningen 2002; 99: 1686–90.
    OpenUrlPubMed
  21. ↵
    Alexandrov AV, Demchuk AM, Felberg RA, Grotta JC, Krieger DW. Intracranial clot dissolution is associated with embolic signals on transcranial Doppler. J Neuroimaging 2000; 10: 27–32.
    OpenUrlPubMed
  22. ↵
    Albin MS HC, Mitzel H, Bunegin L, Gover F. Aeric microemboli and the transcranial doppler (TCD): episodic frequency and timing in 62 cases of open heart surgery. J Neurosurg Anesthesiol 1991; 75: 53.
    OpenUrl
  23. Smith JL, Evans DH, Gaunt ME, London NJ, Bell PR, Naylor AR. Experience with transcranial Doppler monitoring reduces the incidence of particulate embolization during carotid endarterectomy. Br J Surg 1998; 85: 56–9.
    OpenUrlCrossRefPubMed
  24. ↵
    Clark RE, Brillman J, Davis DA, Lovell MR, Price TR, Magovern GJ. Microemboli during coronary artery bypass grafting. Genesis and effect on outcome. J Thorac Cardiovasc Surg 1995; 109: 249–57; Discussion 257–8.
    OpenUrlCrossRefPubMed
  25. ↵
    Nemec JJ, Marwick TH, Lorig RJ, et al. Comparison of transcranial Doppler ultrasound and transesophageal contrast echocardiography in the detection of interatrial right-to-left shunts. Am J Cardiol 1991; 68: 1498–502.
    OpenUrlCrossRefPubMed
  26. ↵
    Droste DW, Reisener M, Kemeny V, et al. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Reproducibility, comparison of 2 agents, and distribution of microemboli. Stroke 1999; 30: 1014–8.
    OpenUrlAbstract/FREE Full Text
  27. Klotzsch C, Janssen G, Berlit P. Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology 1994; 44: 1603–6.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    Zanette EM, Mancini G, De Castro S, Solaro M, Cartoni D, Chiarotti F. Patent foramen ovale and transcranial Doppler. Comparison of different procedures. Stroke 1996; 27: 2251–5.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Petty GW, Mohr JP, Pedley TA, et al. The role of transcranial Doppler in confirming brain death: sensitivity, specificity, and suggestions for performance and interpretation. Neurology 1990; 40: 300–3.
    OpenUrlAbstract/FREE Full Text
  30. Feri M, Ralli L, Felici M, Vanni D, Capria V. Transcranial Doppler and brain death diagnosis. Crit Care Med 1994; 22: 1120–6.
    OpenUrlPubMed
  31. Ropper AH, Kehne SM, Wechsler L. Transcranial Doppler in brain death. Neurology 1987; 37: 1733–5.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Hassler W, Steinmetz H, Pirschel J. Transcranial Doppler study of intracranial circulatory arrest. J Neurosurg 1989; 71: 195–201.
    OpenUrlCrossRefPubMed
  33. ↵
    Lopez-Navidad A, Caballero F, Domingo P, et al. Early diagnosis of brain death in patients treated with central nervous system depressant drugs. Transplantation 2000; 70: 131–5.
    OpenUrlPubMed
  34. ↵
    Muller M, Voges M, Piepgras U, Schimrigk K. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Stroke 1995; 26: 96–100.
    OpenUrlAbstract/FREE Full Text
  35. Markus HS, Harrison MJ. Estimation of cerebrovascular reactivity using transcranial Doppler, including the use of breath-holding as the vasodilatory stimulus. Stroke 1992; 23: 668–73.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Piepgras A, Schmiedek P, Leinsinger G, Haberl RL, Kirsch CM, Einhaupl KM. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide. Stroke 1990; 21: 1306–11.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Silvestrini M, Vernieri F, Pasqualetti P, et al. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000; 283: 2122–7.
    OpenUrlCrossRefPubMed
  38. ↵
    Schondorf R, Benoit J, Wein T. Cerebrovascular and cardiovascular measurements during neurally mediated syncope induced by head-up tilt. Stroke 1997; 28: 1564–8.
    OpenUrlAbstract/FREE Full Text
  39. Ladwig S, Ries S, Henning O, Valikovics A, Daffertshofer M, Pohlmann-Eden B. Combined electroencephalography and measurements of transcranial blood flow velocity during orthostatic testing–a new approach to assess syncope of unknown origin? Clin Auton Res 1997; 7: 305–9.
    OpenUrlCrossRefPubMed
  40. Diehl RR, Linden D, Chalkiadaki A, Ringelstein EB, Berlit P. Transcranial Doppler during neurocardiogenic syncope. Clin Auton Res 1996; 6: 71–4.
    OpenUrlCrossRefPubMed
  41. ↵
    Fredman CS, Biermann KM, Patel V, Uppstrom EL, Auer AI. Transcranial Doppler ultrasonography during head-upright tilt-table testing. Ann Intern Med 1995; 123: 848–9.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family Medicine: 20 (1)
The Journal of the American Board of Family Medicine
Vol. 20, Issue 1
January-February 2007
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Transcranial Doppler: An Introduction for Primary Care Physicians
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Transcranial Doppler: An Introduction for Primary Care Physicians
Mounzer Y. Kassab, Arshad Majid, Muhammad U. Farooq, Hend Azhary, Linda A. Hershey, Edward M. Bednarczyk, Dion F. Graybeal, Mark D. Johnson
The Journal of the American Board of Family Medicine Jan 2007, 20 (1) 65-71; DOI: 10.3122/jabfm.2007.01.060128

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Transcranial Doppler: An Introduction for Primary Care Physicians
Mounzer Y. Kassab, Arshad Majid, Muhammad U. Farooq, Hend Azhary, Linda A. Hershey, Edward M. Bednarczyk, Dion F. Graybeal, Mark D. Johnson
The Journal of the American Board of Family Medicine Jan 2007, 20 (1) 65-71; DOI: 10.3122/jabfm.2007.01.060128
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Examination and Doppler Instrument
    • Introduction to Basic Cerebrovascular Hemodynamics
    • TCD Examination and Interpretation of Findings
    • Basic Observations Regarding Blood FVs and PI in Different Vascular Scenarios
    • Clinical Applications
    • Conclusion: Advantages and Limitations of TCD
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Sex Differences in Middle Cerebral Artery Reactivity and Hemodynamics Independent from Changes in Systemic Arterial Stiffness in Adult Sprague-Dawley Rats
  • Through the looking glass: early non-invasive imaging in TBI predicts the need for interventions
  • HOBOE (Head-of-Bed Optimization of Elevation) Study: Association of Higher Angle With Reduced Cerebral Blood Flow Velocity in Acute Ischemic Stroke
  • Inside the March/April 2008 Issue and the Most Frequently-Read Articles in 2007
  • Google Scholar

More in this TOC Section

  • Practical Recommendations for Minimizing Pain and Anxiety with IUD Insertion
  • A Simplified Approach to Evaluate and Manage Shoulder Pain
  • Treatment of Vasomotor Symptoms
Show more Evidence-Based Clinical Medicine

Similar Articles

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire